The role of advanced glycation end products in modulating healthspan using C. elegans
The role of advanced glycation end products in modulating healthspan using C. elegans
批准号:
9360538
负责人:
Pankaj Kapahi
金额:
$29.1万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-09-30 至 2019-04-30
关键词:
AddressAdultAdvanced Glycosylation End ProductsAgeAgingAnimalsBiochemistryCaenorhabditis elegansCell Culture TechniquesCell LineCellsCellular StressClinicalComplications of Diabetes MellitusDNADetoxification ProcessDevelopmentDiseaseDrug Metabolic DetoxicationEnzymesExhibitsFeedbackGenesGeneticGenetic ModelsGlucoseGlutathioneGlycolysisGlyoxalHumanHyperesthesiaHyperglycemiaImpairmentInvertebratesIon ChannelIonsKnowledgeLactoylglutathione LyaseLinkLipid PeroxidationLipid PeroxidesLipidsLongevityMammalian CellMammalsMediatingModelingMolecularNerve DegenerationNeurodegenerative DisordersNeuronsOrthologous GeneOxidoreductasePARK7 geneParkinson DiseasePathologyPathway interactionsPharmaceutical PreparationsPharmacologyPhenotypePhosphotransferasesPhysiologicalPlayPost-Translational Protein ProcessingProcessProteinsProteomicsPyruvaldehydeReactionRoleSeriesSignal TransductionSiteSpecificityStressSystemTestingThioctic AcidTimeTissuesTouch sensationToxic effectWorkadvanced diseaseage relatedbasediabeticdrug developmentdrug use screeningglycationmutantnew therapeutic targetnovelnuclear factor-erythroid 2podocarpic acidpreventreceptorresponsescreeningsensortandem mass spectrometrytherapeutic targettranscription factor
中文摘要
摘要
衰老和高血糖导致一系列反应性α-二羰基化合物(α-DC,
例如乙二醛/GO、甲基乙二醛/氧化镁、3-脱氧葡萄糖/3DG)和α-DC衍生的代谢物,称为高级
糖基化终产物(AGEs)。AGEs是由于α-DC与蛋白质、脂质和dna反应而形成的。
细胞应激与特定的年龄相关过程、糖尿病并发症和神经退化有关。
因此,防止α-DC和AGE积聚对于延缓衰老和限制
各种与年龄有关的疾病的进展。理解生物化学背后的一个主要瓶颈
这些并发症的进展,以及因此快速的药物开发,是缺乏遗传上易处理的
可以在短时间内概括α-DC和年龄累积影响的模型。为此,我们
建立了一种基于乙醛酶基因受损的秀丽线虫模型,以研究α-DC和
与年龄相关的病理。这些动物表现出几种让人联想到糖尿病并发症的表型,如
由于氧化镁和年龄的积累,以及感觉过敏(或对触摸的高度敏感),在两周内
成人期。最有趣的是,它们表明与年龄相关的神经元损伤增加,寿命缩短。
利用这个模型,我们已经确定了TRPA-1的关键作用,TRPA-1是一种瞬时受体电位(Trp)通道。
感知MGO并激活Nrf2(核因子红系2样蛋白,NFE2L2)以抵消
很久以前了。使用这个模型进行的初步药物筛选已经产生了两种有希望的化合物,它们可以改善
线虫的年龄相关病理通过激活TRPA-1/SKN-1。我们建议使用线虫作为一种
无脊椎动物模型,研究两周内年龄积累的影响,这可能需要数年时间才能形成
在人类中,允许快速发现与衰老和年龄相关的遗传和药理靶点
年龄起重要作用的疾病。
在这项建议中,我们将:1)表征TRPA-1/SKN-1在遗传学和药理学上的作用
解毒氧化镁;2)鉴定介导α-DC解毒的SKN-1下游乙醛酶
如MGO和3)研究TRPA-1/SKN-1途径在哺乳动物MGO解毒中的保守性
人类神经细胞。这些目标将有助于破译α-DC戒毒网络并识别
可减轻糖尿病并发症和延长健康寿命的治疗靶点和新化合物
糖尿病患者。
英文摘要
Summary
Aging and hyperglycemia results in an accumulation of a series of reactive α-dicarbonyl compounds (α-DCs,
e.g. glyoxal/GO, methylglyoxal/MGO, 3-deoxyglucosone/3DG) and α-DC-derived metabolites, called advanced
glycation end products (AGEs). AGEs form due to the reaction of α-DCs with proteins, lipids, and DNA causing
cellular stress linked with specific age-related processes, diabetic complications and neurodegeneration.
Therefore, preventing α-DC and AGE buildup is of quintessential importance for slowing aging and limiting the
progression of various age-related diseases. A major bottleneck in understanding the biochemistry behind the
progression of these complications, and hence rapid drug development, is the lack of genetically tractable
models that can recapitulate the effects of α-DC and AGE accumulation in a short time frame. To that end, we
have established a Caenorhabditis elegans model based on an impaired glyoxalase gene to study α-DC and
AGE-related pathologies. These animals exhibit several phenotypes reminiscent of diabetic complications, such
as accumulation of MGO and AGEs, and hyperesthesia (or hyper sensitivity to touch), within two weeks of
adulthood. Most interestingly they demonstrate increased age-related neuronal damage and shortened lifespan.
Using this model we have identified a critical role for TRPA-1, a transient receptor potential (TRP) channel in
sensing MGO and activating Nrf2 (Nuclear factor erythroid-2 like 2, or NFE2L2) to counteract the effects of
AGEs. A preliminary drug screen using this model has resulted in 2 promising compounds that can ameliorate
AGE-related pathologies in C. elegans through TRPA-1/SKN-1 activation. We propose to use C. elegans as an
invertebrate model to study the effects of AGE accumulation within two weeks which can take years to develop
in humans, to allow rapid discovery of genetic and pharmacological targets relevant to aging and age-related
diseases where AGEs play an important role.
In this proposal we will: 1) Characterize the role of TRPA-1/ SKN-1 both genetically and pharmacologically in
detoxifying MGO; 2) Characterize the glyoxalases downstream of SKN-1 that mediate detoxification of α-DCs
like MGO and 3) examine the conservation of the TRPA-1/SKN-1 pathway in detoxifying MGO in mammals using
human neuronal cells. Together these aims will help to decipher the α-DC detoxification network and identify
therapeutic targets and novel compounds that can mitigate diabetic complications and extend healthspan of
diabetics.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting conserved diet-responsive transcriptional networks in neurons to slow neurodegeneration in Alzheimer's disease
-
批准号:10222430
-
项目类别:
-
资助金额:$53.35万
-
财政年份:2021
-
负责人:Pankaj Kapahi
-
依托单位:
Methylglyoxal drives astrocyte senescence to mediate neurodegeneration in Alzheimer's disease
-
批准号:10794538
-
项目类别:
-
资助金额:$11.54万
-
财政年份:2020
-
负责人:Pankaj Kapahi
-
依托单位:
Methylglyoxal drives astrocyte senescence to mediate neurodegeneration in Alzheimer's disease
-
批准号:10044138
-
项目类别:
-
资助金额:$48.5万
-
财政年份:2020
-
负责人:Pankaj Kapahi
-
依托单位:
Methylglyoxal drives astrocyte senescence to mediate neurodegeneration in Alzheimer's disease
-
批准号:10633000
-
项目类别:
-
资助金额:$8.01万
-
财政年份:2020
-
负责人:Pankaj Kapahi
-
依托单位:
Methylglyoxal drives astrocyte senescence to mediate neurodegeneration in Alzheimer's disease
-
批准号:10222563
-
项目类别:
-
资助金额:$48.5万
-
财政年份:2020
-
负责人:Pankaj Kapahi
-
依托单位:
Methylglyoxal drives astrocyte senescence to mediate neurodegeneration in Alzheimer's disease
-
批准号:10672363
-
项目类别:
-
资助金额:$48.5万
-
财政年份:2020
-
负责人:Pankaj Kapahi
-
依托单位:
Methylglyoxal drives astrocyte senescence to mediate neurodegeneration in Alzheimer's disease
-
批准号:10456805
-
项目类别:
-
资助金额:$48.5万
-
财政年份:2020
-
负责人:Pankaj Kapahi
-
依托单位:
Advanced glycation endproducts (AGEs) as metabolic by-products that mediate neurodegeneration.
-
批准号:10417096
-
项目类别:
-
资助金额:$64.69万
-
财政年份:2019
-
负责人:Pankaj Kapahi
-
依托单位:
Advanced glycation endproducts (AGEs) as metabolic by-products that mediate neurodegeneration.
-
批准号:10624982
-
项目类别:
-
资助金额:$64.69万
-
财政年份:2019
-
负责人:Pankaj Kapahi
-
依托单位:
Advanced glycation endproducts (AGEs) as metabolic by-products that mediate neurodegeneration.
-
批准号:10017128
-
项目类别:
-
资助金额:$64.69万
-
财政年份:2019
-
负责人:Pankaj Kapahi
-
依托单位:
Advanced glycation endproducts (AGEs) as metabolic by-products that mediate neurodegeneration.
-
批准号:10213648
-
项目类别:
-
资助金额:$64.69万
-
财政年份:2019
-
负责人:Pankaj Kapahi
-
依托单位:
The role of advanced glycation end products in modulating healthspan using C. elegans
-
批准号:9255483
-
项目类别:
-
资助金额:$24.25万
-
财政年份:2016
-
负责人:Pankaj Kapahi
-
依托单位:
Role of Circadian Clocks in Aging using Drosophila
-
批准号:8709964
-
项目类别:
-
资助金额:$33.95万
-
财政年份:2013
-
负责人:Pankaj Kapahi
-
依托单位:
Role of Circadian Clocks in Aging using Drosophila
-
批准号:9522362
-
项目类别:
-
资助金额:$19.4万
-
财政年份:2013
-
负责人:Pankaj Kapahi
-
依托单位:
Role of Circadian Clocks in Aging using Drosophila
-
批准号:9298543
-
项目类别:
-
资助金额:$33.95万
-
财政年份:2013
-
负责人:Pankaj Kapahi
-
依托单位:
2013 Aging, Biology of Gordon Research Conference and Gordon Research Seminar
-
批准号:8520639
-
项目类别:
-
资助金额:$5.0万
-
财政年份:2013
-
负责人:Pankaj Kapahi
-
依托单位:
Role of Circadian Clocks in Aging using Drosophila
-
批准号:8880089
-
项目类别:
-
资助金额:$32.93万
-
财政年份:2013
-
负责人:Pankaj Kapahi
-
依托单位:
Role of Circadian Clocks in Aging using Drosophila
-
批准号:8580334
-
项目类别:
-
资助金额:$33.95万
-
财政年份:2013
-
负责人:Pankaj Kapahi
-
依托单位:
A model of kidney stone disease using D. melanogaster
-
批准号:8244229
-
项目类别:
-
资助金额:$25.6万
-
财政年份:2012
-
负责人:Pankaj Kapahi
-
依托单位:
A model of kidney stone disease using D. melanogaster
-
批准号:8471697
-
项目类别:
-
资助金额:$27.17万
-
财政年份:2012
-
负责人:Pankaj Kapahi
-
依托单位:
海外基金